These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 33714753)

  • 21. An Integrated Platform for Serological Detection and Vaccination of COVID-19.
    Wei SC; Hsu WT; Chiu CH; Chang FY; Lo HR; Liao CY; Yang HI; Chou YC; Tsai CH; Chao YC
    Front Immunol; 2021; 12():771011. PubMed ID: 35003088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests.
    De Marco Verissimo C; O'Brien C; López Corrales J; Dorey A; Cwiklinski K; Lalor R; Doyle JM; Field S; Masterson C; Ribes Martinez E; Hughes G; Bergin C; Walshe K; McNicholas B; Laffey JG; Dalton JP; Kerr C; Doyle S
    Epidemiol Infect; 2021 Jun; 149():e140. PubMed ID: 34099081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of Humoral and Cellular Immunity by Intradermal Delivery of SARS-CoV-2 Nucleocapsid Protein Using Dissolvable Microneedles.
    Kuwentrai C; Yu J; Zhang BZ; Hu YF; Dou Y; Gong HR; Huang JD; Xu C
    J Immunol Res; 2021; 2021():5531220. PubMed ID: 34056008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serological response in health care workers after a single dose of SARS-CoV-2 vaccine using six automated SARS-CoV-2 antibody assays.
    Cuykx M; Mortelé O; Jansens H; Schouwers S; Meskal A; Hoffbauer I; Peeters B
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115486. PubMed ID: 34332306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
    Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
    Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleocapsid Antibody Versus Spike Protein Antibody: a Summative Analysis for Diagnosis of SARS-CoV-2 Infection at any Time.
    Tin SS; Wiwanitkit V
    Clin Lab; 2022 Mar; 68(3):. PubMed ID: 35254017
    [No Abstract]   [Full Text] [Related]  

  • 27. Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet!
    Mveang Nzoghe A; Leboueny M; Kuissi Kamgaing E; Maloupazoa Siawaya AC; Bongho EC; Mvoundza Ndjindji O; Padzys GS; Ndeboko B; Ategbo S; Djoba Siawaya JF
    BMC Res Notes; 2021 Apr; 14(1):152. PubMed ID: 33879229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic Studies.
    Loesche M; Karlson EW; Talabi O; Zhou G; Boutin N; Atchley R; Loevinsohn G; Chang JBP; Hasdianda MA; Okenla A; Sampson E; Schram H; Magsipoc K; Goodman K; Donahue L; MacGowan M; Novack LA; Jarolim P; Baden LR; Nilles EJ
    Emerg Infect Dis; 2022 Sep; 28(9):1859-1862. PubMed ID: 35868337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface Plasmon Resonance Immunosensor for Direct Detection of Antibodies against SARS-CoV-2 Nucleocapsid Protein.
    Lisyte V; Kausaite-Minkstimiene A; Brasiunas B; Popov A; Ramanaviciene A
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening and affinity optimization of single domain antibody targeting the SARS-CoV-2 nucleocapsid protein.
    Yang Q; Yan M; Lin J; Lu Y; Lin S; Li Z; Wang H; Yang J; Zhang N; Chen X
    PeerJ; 2024; 12():e17846. PubMed ID: 39224822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Humoral Immune Response against SARS-CoV-2 after Natural Infection and Subsequent Vaccination According to WHO International Binding Antibody Units (BAU/mL).
    Ruetalo N; Flehmig B; Schindler M; Pridzun L; Haage A; Reichenbächer M; Kirchner T; Kirchner T; Klingel K; Ranke MB; Normann A
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Preparation and characterization of monoclonal antibodies against SARS-associated coronavirus nucleocapsid protein].
    Wang YB; Chang ZR; Wang JW; Ji R; Han CH; Zhao L; Ren LL; Chao YG; Qu JG; Qu CY; Hung T
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):316-20. PubMed ID: 15650778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High level SARS-CoV-2 nucleocapsid refolding using mild condition for inclusion bodies solubilization: Application of high pressure at pH 9.0.
    Chura-Chambi RM; Prieto-da-Silva ARB; Di Lela MM; Oliveira JE; Abreu PEA; Meireles LR; de Andrade Junior HF; Morganti L
    PLoS One; 2022; 17(2):e0262591. PubMed ID: 35113919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid Biosensor of SARS-CoV-2 Using Specific Monoclonal Antibodies Recognizing Conserved Nucleocapsid Protein Epitopes.
    Lee JH; Jung Y; Lee SK; Kim J; Lee CS; Kim S; Lee JS; Kim NH; Kim HG
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8
    Ishii H; Nomura T; Yamamoto H; Nishizawa M; Thu Hau TT; Harada S; Seki S; Nakamura-Hoshi M; Okazaki M; Daigen S; Kawana-Tachikawa A; Nagata N; Iwata-Yoshikawa N; Shiwa N; Suzuki T; Park ES; Ken M; Onodera T; Takahashi Y; Kusano K; Shimazaki R; Suzaki Y; Ami Y; Matano T
    Cell Rep Med; 2022 Feb; 3(2):100520. PubMed ID: 35233545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Not Available].
    Béguelin A
    Rev Med Suisse; 2021 Jan; 17(723):234. PubMed ID: 33507668
    [No Abstract]   [Full Text] [Related]  

  • 38. Antigen production and development of an indirect ELISA based on the nucleocapsid protein to detect human SARS-CoV-2 seroconversion.
    Conzentino MS; Forchhammer K; Souza EM; Pedrosa FO; Nogueira MB; Raboni SM; Rego FGM; Zanette DL; Aoki MN; Nardin JM; Fornazari B; Morales HMP; Celedon PAF; Lima CVP; Mattar SB; Lin VH; Morello LG; Marchini FK; Reis RA; Huergo LF
    Braz J Microbiol; 2021 Dec; 52(4):2069-2073. PubMed ID: 34342836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of Detection Antibody Targeting the Linear Epitope in SARS-CoV-2 Nucleocapsid Protein with Ultra-High Sensitivity.
    Wu F; Jiang Y; Yang H; Ma L
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting COVID-19 Severity with a Specific Nucleocapsid Antibody plus Disease Risk Factor Score.
    Sen SR; Sanders EC; Gabriel KN; Miller BM; Isoda HM; Salcedo GS; Garrido JE; Dyer RP; Nakajima R; Jain A; Caldaruse AM; Santos AM; Bhuvan K; Tifrea DF; Ricks-Oddie JL; Felgner PL; Edwards RA; Majumdar S; Weiss GA
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33910993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.